Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.
Wong GS, Zhou J, Liu JB, Wu Z, Xu X, Li T, Xu D, Schumacher SE, Puschhof J, McFarland J, Zou C, Dulak A, Henderson L, Xu P, O'Day E, Rendak R, Liao WL, Cecchi F, Hembrough T, Schwartz S, Szeto C, Rustgi AK, Wong KK, Diehl JA, Jensen K, Graziano F, Ruzzo A, Fereshetian S, Mertins P, Carr SA, Beroukhim R, Nakamura K, Oki E, Watanabe M, Baba H, Imamura Y, Catenacci D, Bass AJ. Wong GS, et al. Among authors: nakamura k. Nat Med. 2018 Jul;24(7):968-977. doi: 10.1038/s41591-018-0022-x. Epub 2018 May 28. Nat Med. 2018. PMID: 29808010 Free PMC article.
A clinicopathological analysis of primary mucosal malignant melanoma.
Izumi D, Ishimoto T, Yoshida N, Nakamura K, Kosumi K, Tokunaga R, Sugihara H, Sawayama H, Karashima R, Imamura Y, Ida S, Hiyoshi Y, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, Watanabe M, Baba H. Izumi D, et al. Among authors: nakamura k. Surg Today. 2015 Jul;45(7):886-91. doi: 10.1007/s00595-014-1041-y. Epub 2014 Oct 9. Surg Today. 2015. PMID: 25297929
Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients.
Kosumi K, Baba Y, Ishimoto T, Harada K, Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Taki K, Higashi T, Miyata T, Kurashige J, Hiyoshi Y, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Kosumi K, et al. Among authors: nakamura k. Surg Today. 2016 Apr;46(4):405-13. doi: 10.1007/s00595-015-1197-0. Epub 2015 Jun 3. Surg Today. 2016. PMID: 26036223
Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer.
Kosumi K, Baba Y, Sakamoto A, Ishimoto T, Harada K, Nakamura K, Kurashige J, Hiyoshi Y, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Hino S, Nakao M, Baba H. Kosumi K, et al. Among authors: nakamura k. Int J Cancer. 2016 Jan 15;138(2):428-39. doi: 10.1002/ijc.29714. Epub 2015 Aug 17. Int J Cancer. 2016. PMID: 26240060 Free article.
Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
Tokunaga R, Imamura Y, Nakamura K, Uchihara T, Ishimoto T, Nakagawa S, Iwatsuki M, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N, Oyama S, Shono T, Naoe H, Saeki H, Oki E, Watanabe M, Sasaki Y, Maehara Y, Baba H. Tokunaga R, et al. Among authors: nakamura k. Cancer Med. 2015 Nov;4(11):1659-66. doi: 10.1002/cam4.514. Epub 2015 Aug 26. Cancer Med. 2015. PMID: 26310928 Free PMC article.
APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.
Kosumi K, Baba Y, Ishimoto T, Harada K, Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Taki K, Higashi T, Miyata T, Shigaki H, Kurashige J, Hiyoshi Y, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H. Kosumi K, et al. Among authors: nakamura k. Med Oncol. 2016 Mar;33(3):26. doi: 10.1007/s12032-016-0739-7. Epub 2016 Feb 15. Med Oncol. 2016. PMID: 26880326
Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma.
Tokunaga R, Imamura Y, Nakamura K, Ishimoto T, Nakagawa S, Miyake K, Nakaji Y, Tsuda Y, Iwatsuki M, Baba Y, Sakamoto Y, Miyamoto Y, Saeki H, Yoshida N, Oki E, Watanabe M, Oda Y, Bass AJ, Maehara Y, Baba H. Tokunaga R, et al. Among authors: nakamura k. Oncotarget. 2016 Apr 12;7(15):19748-61. doi: 10.18632/oncotarget.7782. Oncotarget. 2016. PMID: 26933914 Free PMC article.
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review.
Harada K, Baba Y, Shigaki H, Ishimoto T, Miyake K, Kosumi K, Tokunaga R, Izumi D, Ohuchi M, Nakamura K, Kiyozumi Y, Kurashige J, Iwatsuki M, Miyamoto Y, Sakamoto Y, Yoshida N, Watanabe M, Baba H. Harada K, et al. Among authors: nakamura k. BMC Cancer. 2016 Jul 7;16:400. doi: 10.1186/s12885-016-2422-y. BMC Cancer. 2016. PMID: 27388016 Free PMC article. Review.
14,512 results
You have reached the last available page of results. Please see the User Guide for more information.